Kymera grants PSUs to key employees with three clinical milestone vesting targets

Kymera Therapeutics, Inc.

PSUs vest in three installments: 40% for first milestone, 40% for second, 20% for third.
No PSUs vest before first anniversary of grant date; total payout ranges 0-100% of target.
Grants approved March 3, 2025 under 2020 Stock Plan for named executive officers and management.
Target number of PSUs not disclosed; full award terms to be filed in Q1 2025 10-Q.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.